Literature DB >> 23341521

Molecular profiling of gastric cancer: toward personalized cancer medicine.

Lincoln D Nadauld, James M Ford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23341521     DOI： 10.1200/JCO.2012.47.1714

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  17 in total

1.  Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).

Authors:  Seung Tae Kim; Soomin Ahn; Jeeyun Lee; Su Jin Lee; Se Hoon Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Kyoung-Mee Kim; Joon Oh Park
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-16       Impact factor: 4.553

2.  Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing.

Authors:  Sai Ge; Beifang Li; Yanyan Li; Zhongwu Li; Zhentao Liu; Zuhua Chen; Jian Wu; Jing Gao; Lin Shen
Journal:  Am J Cancer Res       Date:  2017-07-01       Impact factor: 6.166

3.  Effects of laparoscopic radical gastrectomy and the influence on immune function and inflammatory factors.

Authors:  Zhao Ma; Xuebin Bao; Junbao Gu
Journal:  Exp Ther Med       Date:  2016-05-27       Impact factor: 2.447

4.  Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

Authors:  Julian C Schink; Julia R Trosman; Christine B Weldon; Kalliopi P Siziopikou; Gregory J Tsongalis; Alfred W Rademaker; Jyoti D Patel; Al B Benson; Edith A Perez; William J Gradishar
Journal:  J Natl Cancer Inst       Date:  2014-09-12       Impact factor: 13.506

5.  Amplification of the human epidermal growth factor receptor 2 (HER2) gene is associated with a microsatellite stable status in Chinese gastric cancer patients.

Authors:  He Huang; Zhengkun Wang; Yi Li; Qun Zhao; Zhaojian Niu
Journal:  J Gastrointest Oncol       Date:  2021-04

6.  High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.

Authors:  Seokhwi Kim; Jeeyun Lee; Min Eui Hong; In-Gu Do; So Young Kang; Sang Yun Ha; Seung Tae Kim; Se Hoon Park; Won Ki Kang; Min-Gew Choi; Jun Ho Lee; Tae Sung Sohn; Jae Moon Bae; Sung Kim; Duk-Hwan Kim; Kyoung-Mee Kim
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

Review 7.  Emerging molecular classifications and therapeutic implications for gastric cancer.

Authors:  Tao Chen; Xiao-Yue Xu; Ping-Hong Zhou
Journal:  Chin J Cancer       Date:  2016-05-27

8.  Downregulation of ADAMTS8 by DNA Hypermethylation in Gastric Cancer and Its Clinical Significance.

Authors:  Jing Chen; Jiakui Zhang; Xin Li; Chundong Zhang; Hongbin Zhang; Junzhe Jin; Dongqiu Dai
Journal:  Biomed Res Int       Date:  2016-07-14       Impact factor: 3.411

9.  HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma.

Authors:  Y J Liu; D Shen; X Yin; P Gavine; T Zhang; X Su; P Zhan; Y Xu; J Lv; J Qian; C Liu; Y Sun; Z Qian; J Zhang; Y Gu; X Ni
Journal:  Br J Cancer       Date:  2014-02-11       Impact factor: 7.640

Review 10.  Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.

Authors:  Ismael Riquelme; Kathleen Saavedra; Jaime A Espinoza; Helga Weber; Patricia García; Bruno Nervi; Marcelo Garrido; Alejandro H Corvalán; Juan Carlos Roa; Carolina Bizama
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.